OXFORD, United Kingdom and MARLBOROUGH, Mass., Aug. 20, 2015 (GLOBE NEWSWIRE) --
Oxford Immunotec Global PLC (Nasdaq:OXFD), a global, commercial-stage
diagnostics company focused on developing and commercializing proprietary tests
for the management of immune-regulated conditions, today announced ...
↧